Source: Eur Respir J 2009; 34: 276
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Spiekermann S. , Schenk K. , Hoeper M. M.. Increased xanthine oxidase activity in idiopathic pulmonary arterial hypertension. Eur Respir J 2009; 34: 276

Member's Comments

No comment yet.

Related content which might interest you: The effect of Monoamine oxidase A inhibition on experimentally induced pulmonary arterial hypertension Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Localisation of NADPH oxidases and their role in hypoxia induced pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 804s Year: 2006 Increased renin-angiotensin-aldosteron system activity in lungs of patients with idiopathic pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Differences in the activity of the angiotensin converting enzyme 2 axis in patients with idiopathic pulmonary arterial hypertension and congenital heart defect related pulmonary hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Targeting of mitochondrial superoxide in chronic hypoxia-induced pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Profiling nitric oxide metabolites in patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 1386-1395 Year: 2016 Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension Source: Eur Respir J, 56 (5) 2000522; 10.1183/13993003.00522-2020 Year: 2020 Effect of the Asp298 variant of endothelial nitric oxide synthase on acute pulmonary vasodilator testing response in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 547s Year: 2006 Exercise-induced pulmonary hypertension in patients with idiopathic pulmonary fibrosis: effects of oxygen Source: Eur Respir J 2007; 30: Suppl. 51, 607s Year: 2007 Chronic hypoxia-induced pulmonary hypertension is linked to a decrease in the soluble epoxide hydrolase Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009 Early atorvastatin administration suppresses the oxygen-activating ability of rat neutrophils during monocrotalinin-induced pulmonary arterial hypertension (PAH). Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 High prevalence of iron deficiency in idiopathic pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Iron deficiency in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways Source: Eur Respir J 2003; 22: 457-461 Year: 2003 Novel biomarkers in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Platelet activity in patients with COPD and concomitant arterial hypertension Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 Tobacco smoke-induced emphysema and pulmonary hypertension – Role of NADPH oxidase NOX2 Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010 Improvement of exercise capacity in monocrotaline induced pulmonary hypertension by the phosphodiesterase inhibitor Vardenafil Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Bosentan influence on catecholamines levels in patients with idiopathic arterial pulmonary hypertenson Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments Year: 2012 Evaluation of serum cytokines in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension with hypercholesterolemia Source: International Congress 2017 – PAH and CTEPH Year: 2017